Antiretroviral therapy coverage among people with advanced HIV infection (%), WHO 2006 guidelines
Water, sanitation and hygiene attributable deaths per 100'000 capita
Water, sanitation and hygiene  attributable deaths per 100'000 children under 5 years
Water, sanitation and hygiene attributable DALYs ('000)
Ambient air pollution  attributable deaths per 100'000 children under 5 years
Household air pollution attributable deaths per 100'000 capita
Distribution of years of life lost by broader causes (%) - Injuries
Number of pharmaceutical personnel
Density of pharmaceutical personnel (per 10 000 population)
Ambient air pollution attributable deaths
Number of nursing and midwifery personnel
Nursing and midwifery personnel density (per 10 000 population)
Total density per 100 000 population: Health posts
Total density per 100 000 population: Specialized hospitals
Total density per million population: Magnetic Resonance Imaging
Total density per million population: Positron Emission tomography
Type of nomenclature system
Health technology (medical device) national policy
Procurement of medical devices carried out at the national level
Types of lists recommending health technology for high burden diseases
Number of national population surveys - child anthropometry
Number of national population surveys - child mortality
Number of national population surveys - maternal mortality
Number of national population surveys -  HIV prevalence
Number of under-five deaths from malaria
Distribution of causes of death among children aged <5 years (%) - Measles
Distribution of causes of death among children aged <5 years (%) - Malaria
Distribution of causes of death among children aged <5 years (%) - Pneumonia
Distribution of causes of death among children aged <5 years (%) - Injuries
Distribution of causes of death among children aged <5 years (%) - Other diseases
Distribution of causes of death among children aged <5 years (%) - HIV/AIDS
Distribution of causes of death among children aged <5 years (%) - Diarrhoea
Distribution of causes of death among children aged <5 years (%) - Prematurity
Distribution of causes of death among children aged <5 years (%) - Birth asphyxia
Distribution of causes of death among children aged <5 years (%) - Neonatal sepsis
Distribution of causes of death among children aged <5 years (%) - Congenital anomalies
Tuberculosis - new and relapse cases
Commitments to recipient countries (Million, constant 2009 US$)
Disbursements to recipient countries (Million, constant 2009 US$)
Annual incidence of dracunculiasis cases
Net primary school enrolment ratio (%)
Number of reported deaths from cholera
Percentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packaging
Font style, font size and colour of health warnings are mandated for other smoked tobacco packaging
Health warnings on other smoked tobacco packaging must include a photograph or graphic
Current smokers of cigarettes (youth rate)
Exposure to smoke outside home
Health warnings on other smoked tobacco packaging must be rotated
Health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale
Year of survey of youth
Smoking cessation support is available in hospitals
Smoking cessation support is available in health clinics or other primary care facilities
Smoking cessation support is available in offices of health professionals
Nicotine replacement therapy - place available
Bupropion - legally sold
Varenicline - place available
Fines on the patron
Dedicated funds for enforcement
Number of reported cases of cholera
Raised total cholesterol (>= 5.0 mmol/L) (crude estimate)
Raised total cholesterol (&#8805; 6.2 mmol/L) (age-standardized estimate)
Mean BMI (kg/m&#xb2;) (crude estimate)
Mean Total Cholesterol (crude estimate)
Mean Total Cholesterol (age-standardized estimate)
Mean fasting blood glucose (mmol/l) (crude estimate)
Mean systolic blood pressure (crude estimate)
Existence of a formal pre-hospital care system
Population
Age-standardized death rates (15+ years), violence, per 100,000
Age-standardized death rates, colon and rectum cancers, per 100,000
Age-standardized death rates, falls, per 100,000
Age-standardized death rates (15+ years), poisoning, per 100,000
Age-standardized death rates, drownings, per 100,000
Age-standardized death rates, liver cancer, per 100,000
Age-standardized death rates (15+ years), alcoholic liver disease, per 100,000
Age-standardized death rates, fires, per 100,000
Treatment, services
Production in 1000s hectolitres
Imports in 1000s hectolitres
Sales of wine in 1000s hectolitres
Exports of beer (barley) in 1000s hectolitres
Exports of spirits in 1000s hectolitres
Exports of wine (grape) in 1000s hectolitres
Sales of beer in 1000s hectolitres
Service delivery data collection system for substance use disorders
Epidemiological data collection system for substance use disorders
National survey on substance use among children and adolescents
Treatment system for substance use disorders
Sector for inpatient treatment of drug dependence
Sector for inpatient detoxification of alcohol use disorders
Governement benefits for persons with substance use disorders
Treatment setting for substance use disorders, most common
Sector for residential long-term rehabilitation of drug use disorders
Sector for inpatient treatment of alcohol dependence
Pharmacotherapy used for the management of benzodiazepine withdrawal
Essential list of medicines, pharmacotherapy for substance use disorders
Pharmacotherapy used for the management of alcohol withdrawal
Essential list of medicines
Age-standardized death rates, ischaemic heart disease, per 100,000
Age-standardized death rates, oesophagus cancer, per 100,000
Age-standardized death rates, poisoning, per 100,000
Age-standardized death rates, self-inflicted injury, per 100,000
Age-standardized DALYs, cerebrovascular disease, per 100,000
Age-standardized DALYs, diabetes mellitus, per 100,000
Age-standardized DALYs, falls, per 100,000
Age-standardized DALYs, ischaemic heart disease, per 100,000
Age-standardized DALYs, mouth and oropharynx cancer, per 100,000
Age-standardized DALYs, poisoning, per 100,000
Age-standardized DALYs, self-inflicted injury, per 100,000
Age-standardized DALYs, prematurity and low birth rate, per 100,000
NGOs for alcohol use disorders
Groups and agencies for the prevention of substance use disorders
Age-standardized death rates, alcohol and drug use disorders, per 100 000
Programmes for the prevention of substance use disorders for special populations
Budget line for substance use disorder prevention
Screening and brief interventions for substance use and substance use disorders
Substance use policy at the national level
Training in screening and brief interventions for alcohol problems
Designation of alcohol tax revenues to health services
Number of other health workers
New cases: pulmonary smear-negative
New cases: pulmonary smear unknown/not done
New cases: other
Retreatment cases: treatment after failure (pulmonary smear and/or culture positive)
Retreatment cases: treatment after default (pulmonary smear and/or culture positive)
Retreatment cases: other
Smear-positive tuberculosis treatment-success rate (%)
Confirmed cases of MDR-TB
Government expenditures on mental health as a percentage of total government expenditures on health (%)
Sex workers with active syphilis (%)
Antiretroviral therapy coverage among people with HIV infection eligible for ART according to 2010 guidelines (%)
Use of nomenclature system
Availability of national standards or recommended lists of medical devices
Total density per 100 000 population: Health centres
Total density per million population: Radiotherapy units
Total density per million population: Telecobalt Unit
Deaths due to HIV/AIDS (per 100 000 population)
Preparedness
Risk communication
Human resources
Laboratory
Zoonosis
Food safety
Chemical
Radionuclear
Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016
Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol)
Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol)
Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI
Age-standardized DALYs (per 100,000)
15-19 years old former drinkers (%)
Most recent census (year)
Cholera case fatality rate
Smear-positive tuberculosis case-detection rate (%)
Water, sanitation and hygiene attributable deaths ('000) in children under 5 years
Ambient air pollution (Annual PM10 [ug/m3])
UV radiation
UV radiation attributable deaths per 100'000 capita
Low-birth-weight newborns (%)
Radiotherapy units (per 1 000 000 population)
Prevalence of current tobacco use among adolescents (13-15 years) (%)
Adults aged &#8805; 20 years who are obese (%)
Reported number of children receiving antiretroviral therapy, month and year of report
Prevalence of smoking any tobacco product among adults (&#8805;15 years) (%)
Number of dentistry personnel
Total density per 100 000 population: District/rural hospitals
Total density per 100 000 population: Provincial hospitals
National guidelines, policies or recommendations on the procurement of medical devices
Antenatal care attendees who were positive for syphilis (%)
Women accessing antenatal care (ANC) services who were tested for syphilis (%)
Preterm birth rate (per 100 live births)
Basis for NHA estimate
Daily users of any smokeless tobacco product (crude rate)
Health warnings on other smoked tobacco packaging must be written in the principal language(s) of the country
Repeating interval for survey of youth (years)
Representativeness of youth survey
Access to a toll-free quit line
Bupropion - place available
Varenicline - legally sold
Fines for violations
Fines on the establishment
Raised total cholesterol (>= 5.0 mmol/L) (age-standardized estimate)
Raised total cholesterol (&#8805; 6.2 mmol/L) (crude estimate)
Age-standardized death rates, alcohol use disorders, per 100,000
Monitoring
Perceived trend in sales
Data on substance use disorders disseminated in national annual reports
Confidentiality of health records on substance use disorders  protected by law
Legislative provision for treatment and rehabilitation of substance use disorders
Government unit for substance use disorder treatment
Sector for inpatient detoxification of drug use disorders
Financing method for substance use disorder treatment
Sector for the treatment of alcohol-induced psychoses and other alcohol-induced psychiatric conditions
Sector for outpatient treatment of alcohol dependence
Open access services for substance use disorders
Pharmacotherapy used for the management of cannabis withdrawal
Age-standardized death rates, breast cancer, per 100,000
Age-standardized death rates, cerebrovascular disease, per 100,000
Age-standardized death rates, diabetes mellitus, per 100,000
Age-standardized death rates, liver cirrhosis, per 100,000
Age-standardized death rates, mouth and oropharynx cancer, per 100,000
Age-standardized death rates, other unintentional injuries, per 100,000
Age-standardized death rates, prematurity and low birth rate, per 100,000
Age-standardized death rates, road traffic accidents, per 100,000
Age-standardized death rates, violence, per 100,000
Age-standardized DALYs, alcohol use disorders, per 100,000
Age-standardized DALYs, breast cancer, per 100,000
Age-standardized DALYs, liver cancer, per 100,000
Age-standardized DALYs, other unintentional injuries, per 100,000
Social costs of alcohol use in millions US$
Self-help groups for substance use disorders
Standards of care for health professionals
Health professionals mostly involved in treatment of substance use disorders
NGOs for drug use disorders
Clinical supervision of health care staff
Age-standardized DALYs, alcohol and drug use disorders, per 100 000
Harm reduction programmes for IDUs
Funding method for substance use disorder prevention
Government unit for substance use disorder prevention
Opioid agonist pharmacotherapy for the treatment of opioid dependence (detoxification or maintenance)
Substance use policy at the national level, level of integration
System for monitoring alcohol-related harm
Persons with alcohol use disorders receiving treatment (%)
Poverty headcount ratio at $1.25 a day (PPP) (% of population)
Confirmed cases of MDR-TB started treatment for MDR-TB (%)
Mental health policy
Mental health plan
Prices for alcoholic beverages (average, US$)
Excise tax as a per cent of the retail price of alcoholic beverages
Antenatal care attendees positive for syphilis who received treatment (%)
Availability of national list of approved medical devices for procurement or reimbursement
Total density per million population: Computed tomography units
Legislation
Surveillance
Alcohol, patterns of drinking score
Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010
Alcohol, total  (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2025
Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average
Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CI
15-19 years old abstainers, lifetime (%)
Civil registration coverage of cause-of-death (%)
Distribution of years of life lost by major cause group
Number of reported cases of tuberculosis (DOTS)
Household air pollution  attributable deaths per 100'000 children under 5 years
Household air pollution  attributable DALYs per 100'000 children under 5 years
UV radiation attributable DALYs per 100'000 capita
Dentistry personnel density (per 10 000 population)
Density of environment and public health workers (per 10 000 population)
Total density per million females aged from 50 to 69 years old: Mammography units
International Statistical Classification of Diseases and Related Health Problems (ICD)
Number of national population surveys -  adult health
Percentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packaging
Specific health warnings are mandated for other smoked tobacco packaging
Exposure to smoke at home
Percentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packaging
Health warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on health
Nicotine replacement therapy - legally sold
Citizen complaints and investigations
Gross national income per capita (Atlas method)
Perceived trend in production
Perceived trend in exports
Point prevalence (%), alcohol use disorders, 15+ years
Point prevalence (%), drug use disorders, 15+ years
Programmes diverting clients from the justice system towards treatment
Drug courts
Budget line for substance use disorder treatment
Policy documents on the pharmacological treatment of substance use disorders
Specialized treatment services for substance use disorders and TB
Sector for outpatient treatment of drug dependence
Treatment slots for alcohol and drug use disorders, outpatient, per 10 000
Sector for residential long-term rehabilitation of alcohol use disorders
Age-standardized DALYs, colon and rectum cancers, per 100,000
Age-standardized DALYs, drownings, per 100,000
Age-standardized DALYs, fires, per 100,000
Age-standardized DALYs, liver cirrhosis, per 100,000
Age-standardized DALYs, oesophagus cancer, per 100,000
Age-standardized DALYs, road traffic accidents, per 100,000
Age-standardized DALYs, violence, per 100,000
Prevention activities for substance use disorders, main focus
Buprenorphine used for the treatment of opioid dependence
Opioid agonist pharmacotherapy for the treatment of opioid dependence (maintenance)
Alcohol-related injury mortality, per 1,000
Prevention/counselling at workplaces for those with alcohol problems
Interventions/projects actively involving young people and civil society
Perceived trend in alcohol-related harm and consequences
Gender inequality index rank
ICT Development Index (IDI) rank
ICT Development Index (IDI)
Percentage of individuals using the Internet
Excise tax as a per cent of the total retail price for 1 litre of pure alcohol
Mobile-cellular telephone subscriptions per 100 inhabitants
Dracunculiasis certification status of countries at the beginning of the year
Estimated number of people eligible for antiretroviral therapy according to 2010 guidelines
Availability of technical specifications of medical devices to support procurement or donations
Unit in the Ministry of Health responsible for the management of medical devices
Total density per million population: Linear Accelerator
Coordination
Response
Civil registration coverage of births (%)
Maternal mortality ratio (per 100 000 live births) - Country reported estimates
Water, sanitation and hygiene attributable DALYs ('000) in children under 5 years
Water, sanitation and hygiene attributable DALYs per 100'000 capita
Water, sanitation and hygiene  attributable DALYs per 100'000 children under 5 years
Percentage of the total population living in cities > 100'000 inhabitants
Ambient air pollution  attributable DALYs per 100'000 children under 5 years
UV radiation attributable deaths
UV radiation attributable DALYs ('000)
Civil registration coverage of causes of deaths (%)
Number of environment and public health workers
Ambient air pollution in urban areas (Annual PM<sub>10</sub> [&#956;g/m<sup>3</sup>])
Percent of urban inhabitants living in cities covered by PM measurements
Cellular subscribers (per 100 population)
Number of cause-of-death registration years available
Cholera - number of reported cases
Number of health warnings approved by the law for other smoked tobacco packaging
Smoking cessation support is available in the community
Smoking cessation support is available in other settings
Income level
Perceived trend in imports
Legislative provision for compulsory treatment
Guidelines on the pharmacological treatment of substance use disorders
Specialized treatment services for drug use disoders and HIV/AIDS
Psychoactive substance causing entry into treatment
Buprenorphine/naloxone used for the treatment of opioid dependence
Methadone used for the treatment of opioid dependence
Community-based interventions/projects involving stakeholders
Public-funded alcohol research/monitoring programmes
Public funds designated for alcohol research/monitoring programmes, in Euros
National treatment policy for alcohol use disorders
National surveys on drink-driving
Counselling to children in families with alcohol problems
Data collection on alcohol-related health indicators
Counselling to pregnant women with alcohol problems
Population median age (years)
Human development index rank
Points of entry
Alcohol, tourist consumption (in litres of pure alcohol)
Regular reports from national monitoring systems
Status of bejel endemicity
Gross national income per capita (PPP int. $)
Total density per 100 000 population: Hospitals
Prevalence of smoking any tobacco product among persons aged >= 15 years
General availability of insulin in the public health sector
General availability of oral morphine in the public health sector
General availability of thiazide diuretics in the public health sector
Existence of an NCD surveillance and monitoring system in place to enable reporting against the nine global NCD targets
15-years old any alcoholic beverage consumed in past 30 days, (%)
Existence of operational policy/strategy/action plan for cardiovascular diseases
Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities)
Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
Ban on advertising: Point of sale
Appearance of tobacco products in TV and/or films
Ban on display of tobacco products at points of sale
Compliance with regulations on smoke-free environments (national legislation)
Subnational bans on tobacco advertising, promotion and sponsorship
Tax structure: Excise tax proportion of price
Adult indicator 2 definition
Name of survey of youth
Adult smokeless tobacco use indicator definition
Compliance of ban on smoking in HEALTH-CARE FACILITIES
Compliance of ban on smoking in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES
Compliance of ban on smoking in UNIVERSITIES
Compliance of ban on smoking in INDOOR OFFICES
Compliance of ban on smoking in RESTAURANTS
Compliance of ban on smoking in PUBS AND BARS
Compliance of ban on smoking in PUBLIC TRANSPORT
Compliance of ban on appearance of tobacco brands in TV and/or films (product placement)
Compliance of ban on appearance of tobacco products in TV and/or films
Compliance of ban on sponsored events
Compliance of ban on advertising on billboards and outdoor advertising
Compliance of ban on advertising on local magazines and newspapers
Adult survey age range
Comprehensive bans in place subnationally
Adult indicator 1 rate
Youth smokeless tobacco use indicator rate
Average - taxes as a % of cigarette price - other taxes
Average - taxes as a % of cigarette price - import duties
Average - taxes as a % of cigarette price - specific excise
Average - taxes as a % of cigarette price - value added tax
Average - taxes as a % of cigarette price - ad valorem excise
Prevalence of tuberculosis (per 100 000 population)
Number of prevalent tuberculosis cases
Laboratories providing drug susceptibility testing (DST) (per 5 million population)
Laboratories providing tuberculosis diagnostic services using sputum smear microscopy (per 100 000 population)
Laboratories providing tuberculosis diagnostic services using culture (per 5 million population)
Total number of notified TB cases
Congenital syphilis rate per 100 000 live births
Age-standardized deaths attributable to the environment (per 100 000 population)
Disability-adjusted life years (DALYs) attributable to the environment
Age-standardized DALYs attributable to the environment (per 100 000 population)
Deaths attributable to the environment
Testing and counselling facilities, estimated number per 100 000 adult population
Number of people aged 15 years and over who received HIV testing and counselling, reporting period
People aged 15 years and over who received HIV testing and counselling, estimated number per 1000 adult population
Children aged <5 years overweight (%)
Children aged <5 years stunted (%)
Children aged <5 years underweight (%)
Children aged <5 years wasted for age (%)
15-19 years old total alcohol consumption in litres of pure alcohol
Contraceptive prevalence (%)
General availability of breast cancer screening (by palpation or mammogram) at the primary health care level
General availability of diabetes testing (by blood glucose measurement, OGTT, or HbA1c) at the primary health care level
General availability of ACE inhibitors in the public health sector
General availability of CC blockers in the public health sector
General availability of nicotine replacement therapy in the public health sector
Existence of operational policy/strategy/action plan for diabetes
Existence of operational policy/strategy/action plan to reduce physical inactivity
Existence of operational policy/strategy/action plan to reduce unhealthy diet related to NCDs
Literacy rate among adults aged >= 15 years (%)
Compliance with bans on direct advertising
Compliance of ban on advertising on national TV and radio
Compliance of ban on smoking in GOVERNMENT FACILITIES
Compliance of ban on free distribution of tobacco products in the mail or through other means
Ban on tobacco companies/tobacco industry publicizing their “Corporate Social Responsibility” activities
Required anti-tobacco ads for any visual entertainment media product that depicts tobacco products, use or images
Law requires fines for violations of indirect advertising bans
Ban on entities other than tobacco companies/tobacco industry publicizing the Corporate Social Responsibility� activities of the tobacco companies
Youth indicator 1 definition
Representativeness of survey of adults
Subnational advertising, promotion and sponsorship bans - at least one jurisdiction has a comprehensive ban in place
Compliance of ban on brand name of non-tobacco products used for tobacco product
Compliance of ban on non-tobacco goods AND services identified with tobacco brand names
Compliance of ban on promotional discounts
Compliance with bans on promotion and sponsorship
Adult indicator 2 rate
Youth indicator 2 rate
Average - taxes as a % of cigarette price - total tax
Second-line drug susceptibility testing (DST) available
Congenital syphilis number of reported cases
Deaths attributable to the environment (%)
Testing and counselling facilities, reporting period
Number of people aged 15 years and over who received HIV testing and counselling, reported number
Number of deaths
Status of pinta endemicity
General availability of colon cancer screening at the primary health care level
General availability of urine testing for albumin
General availability of bronchodilators in the public health sector
General availability of metformin in the public health sector
General availability of statins in the public health sector
Existence of an Operational Unit, Branch, or Dept. in Ministry of Health with responsibility for NCDs
Existence of operational policy/strategy/action plan to decrease tobacco use
Mental hospital admissions (per 100 000 population)
Outpatient visits (per 100 000 population)
Compliance of ban on advertising at point of sale
Complete ban on tobacco vending machines
Sponsored events
Youth survey age range
Tax administration: Bans or limits on duty free imports by travellers
Tax administration: Tax stamps applied on tobacco products
Tobacco excises increased over the survey period
Youth indicator 1 rate
Tax administration: If duty free imports are limited, duty free allowance (number of cigarette sticks)
Estimated MDR-TB cases among notified pulmonary TB cases
General availability of cervical cytology at the primary health care level
General availability of total cholesterol measurement at the primary health care level
General availability of peak flow measurement spirometry at the primary health care level
General availability of aspirin (100 mg) in the public health sector
General availability of steroid inhalers in the public health sector
Population using solid fuels (%)
Existence of operational policy/strategy/action plan for cancer
Existence of operational policy/strategy/action plan for chronic respiratory diseases
Existence of operational policy/strategy/action plan to reduce the harmful use of alcohol
Population living on <$1 (PPP int. $) a day (%)
Mental health units in general hospitals admissions (per 100 000 population)
Stand-alone law for mental health
Stand-alone policy or plan for mental health
Law requires fines for violations of direct advertising bans
Adult indicator 1 definition
Youth indicator 2 definition
Affordability: Cigarettes are less affordable in 2014 compared to 2008
Name of survey of adults
Youth smokeless tobacco use indicator definition
Process evaluation was employed to assess implementation
Private prepaid plans as a percentage of private expenditure on health
Per capita government expenditure on health at average exchange rate (US$)
Per capita total expenditure on health (PPP int. $)
Per capita government expenditure on health (PPP int. $)
General government expenditure on health as a percentage of total government expenditure
External resources for health as a percentage of total expenditure on health
Social security expenditure on health as a percentage of general government expenditure on health
Out-of-pocket expenditure as a percentage of private expenditure on health
Total expenditure on health as a percentage of gross domestic product
Private expenditure on health as a percentage of total expenditure on health
General government expenditure on health as a percentage of total expenditure on health
Per capita total expenditure on health at average exchange rate (US$)
Reported number of human rabies deaths
Out-of-pocket expenditure as a percentage of total expenditure on health
Existence of a national multisectoral commission, agency or mechanism for NCDs
Population living in urban areas (%)
Existence of a diabetes registry
Most widely used screening method in national cervical cancer screening program
Existence of national HPV vaccination programme
Provision for care of acute stroke and rehabilitation in more than 50% of public sector health facilities
General availability of sulphonylurea(s) in the public health sector
DALYs attributable to ambient air pollution (age-standardized)
Raised blood pressure (SBP>=140 OR DBP>=90) (age-standardized estimate)
Raised blood pressure (SBP>=140 OR DBP>=90) (crude estimate)
Mean systolic blood pressure (age-standardized estimate)
Specific absorption rate (SAR) (W/kg)
Power density (W/m^2)
Existence of standards
Access restrictions
Restriction and inspection of facilities
Year of national implementation of regulation
Ministry/office that takes primary responsibility for treatment of substance use disorders
Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for treatment of substance use disorders
Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for treatment of substance use disorders
Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for prevention for alcohol and drugs
Five years change in international cooperation for treatment of substance use disorders
Compulsory treatment for people with drug use disorders in the criminal justice system
Financing methods for treatment for alcohol use disorders
Government benefits for people with drug use disorders
Specialized treatment facilities for substance use disorders
Pharmacotherapy with buprenorphine
Registration of medications for opioid dependence
Prevention programmes for alcohol
Ambient air pollution attributable DALYs
Prevention programmes for specific populations for drugs
HIV, Hepatitis counselling and treatment availability in specialized facilities and services
Programmes readily available
Treatment programmes for women with drug use disorders
Special housing services for drug use disorders
Employment services for alcohol use disorders
Employment services for drug use disorders
Open access interventions for drugs
Health professionals providing treatment for alcohol and drug use disorders
Educational attainment in prevention
Continuing professional development in prevention
Continuing professional development in treatment
Treatment programmes for children and adolescents with alcohol use disorders
Treatment programmes for children and adolescents with drug use disorders
Standards of care for professionals providing treatment for alcohol and drug use disorders
Postgraduate training programme in treatment
Access restrictions to maintenance treatment
Registration of naloxone for injection for opioid overdose
Groups and agencies involved in prevention programs
Prevention programmes for specific populations for alcohol
Self-help groups
Prevalence of obesity among adults, BMI &GreaterEqual; 30 (age-standardized estimate) (%)
Prevalence of obesity among adults, BMI &GreaterEqual; 30 (crude estimate) (%)
Prevalence of underweight among adults, BMI < 18.5 (age-standardized estimate) (%)
Prevalence of underweight among adults, BMI < 18.5 (crude estimate) (%)
Existence of population-based cancer registry
Existence of a set of national NCD indicators and has set time-bound national targets for these indicators
Existence of any policies on marketing of foods to children
General availability of diabetes testing (by HbA1c) at the primary health care level
Coverage of national cervical cancer screening program (%)
General availability of dialysis in the public health system
General availability of coronary bypass or stenting in the public health system
General availability of palliative care in community or home-based care in the public health system
General availability of beta blockers in the public health sector
Existence of an operational, multisectoral national NCD policy, strategy or action plan that integrates several NCDs and their risk factors
Provision for secondary prevention of rheumatic fever and rheumatic heart disease in more than 50% of public sector health facilities
Number of licensed qualified obstetricians actively working
Electric field (V/m)
Training requirements
Information requirements
Existence of national regulation
Government unit/official responsible for prevention for substance use
Government unit/official responsible for treatment of substance use disorders
Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for prevention for alcohol and drugs
Compulsory treatment for people with alcohol use disorders in the criminal justice system
Five-year change in government resources for prevention for substance use
Five-year change in government resources for treatment of substance use disorders
Financing methods for treatment for drug use disorders
Government benefits for people with alcohol use disorders
Main sector for treatment for drug use disorders
Specialized treatment facilities for alcohol use disorders
Specialized treatment facilities for drug use disorders
Main substance at treatment entry
Screening and brief intervention for substance use in primary health care
Screening and brief intervention for substance use in antenatal services
Recommendations for screening and brief interventions for substance use in primary health care
Recommendations for screening and brief interventions for substance use in antenatal services
Prevention programmes for drugs
Standards of treatment and care for public specialized treatment facilities
Special treatment programmes for gambling disorder
Special housing services for alcohol use disorders
Postgraduate training programme in prevention
Educational attainment in treatment
Service delivery data collection for substance use
Regular reports on epidemiological and service delivery data for substance use
Epidemiological data collection system for substance use among children and adolescents
System of monitoring drugs involvement in forensic pathology
Five years change in international cooperation for prevention for substance use
Hypothecated taxes to be spent on prevention and treatment for substance use disorders
Timeframe for maintenance treatment of opioid dependence
Mean BMI (kg/m&#xb2;) (age-standardized estimate)
Existence of any policies to reduce population salt consumption
Implementation of diet and/or physical activity public awareness program
General availability of diabetes testing (by blood glucose measurement, OGTT) at the primary health care level
Existence of national screening program for breast cancer
Type of national cervical cancer screening program
General availability of retinal photocoagulation in the public health system
General availability of renal replacement by transplantation in the public health system
General availability of thrombolytic therapy in the public health system
Availability of cardiovascular risk stratification in 50% or more primary health care facilities
Number of licensed qualified anaesthesiologists actively working
Existence of subnational regulation
Ministry/office that takes primary responsibility for prevention for substance use
Pharmacotherapy with methadone
Availability of naloxone
Ambient air pollution attributable deaths (per 100 000 population, age-standardized)
Adolescent mortality rate (per 100 000 population)
Voluntary treatment for people with drug use disorders in the criminal justice system
Open access interventions for alcohol
Adult smokeless tobacco use indicator rate
Disability-adjusted life years (DALYs) attributable to the environment (%)
Testing and counselling facilities, reported number
Has a STEPS survey or a comprehensive health examination survey every 5 years
Existence of national screening program for cervical cancer
General availability of palliative care in primary health care in the public health system
Number of licensed qualified surgeons actively working
Countries that have passed legislation on Universal Health Coverage (UHC)
Total net official development assistance to medical research and basic health sectors per capita (constant 2014 US$), by recipient
Safety requirements
Confidentiality of people in treatment for substance use disorders
Voluntary treatment for people with alcohol use disorders in the criminal justice system
Guidelines on pharmacological treatment for substance use disorders
Pharmacotherapy with buprenorphine/naloxone
Registration of medications for alcohol dependence and withdrawal
Registration of medications for opioid withdrawal
Treatment programmes for women with alcohol use disorders
Epidemiological data collection for substance use
System of monitoring alcohol involvement in forensic pathology
Prevalence of overweight among adults, BMI &GreaterEqual; 25 (age-standardized estimate) (%)
Prevalence of overweight among adults, BMI &GreaterEqual; 25 (crude estimate) (%)
Prevalence of overweight among children and adolescents, BMI > +1 standard deviations above the median (crude estimate) (%)
Prevalence of obesity among children and adolescents, BMI > +2 standard deviations above the median (crude estimate) (%)
Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (crude estimate) (%)
Raised fasting blood glucose (>= 7.0 mmol/L or on medication) (crude estimate)
Raised fasting blood glucose (>=7.0 mmol/L or on medication)(age-standardized estimate)
Identification of other plans in which dementia is integrated (Mental health)
Identification of other plans in which dementia is integrated (Ageing)
Identification of other plans in which dementia is integrated (NCD)
Identification of other plans in which dementia is integrated (Disability)
Inclusion of improved information system as a specific action of the dementia plan
Inclusion of research and innovation as a specific action of the dementia plan
Existence of dementia legislation
Implementation level [national/subnational] of dementia legislation
Existence of approved government dementia standards/ guidelines/ protocols
Existence of standards/ guidelines/ protocols for prevention and risk reduction of dementia
Existence of standards/ guidelines/ protocols for diagnosis of dementia
Existence of standards/ guidelines/ protocols for management of dementia
Existence of standards/ guidelines/ protocols for other post-diagnostic supports of people with dementia
Identification of different sectors in dementia care coordination (Civil society)
Identification of different sectors in dementia care coordination (Private sector)
Identification of different sectors in dementia care coordination (Other)
Implementation level [national/subnational] of dementia care coordination
Accessibility of diagnostic services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]
Majority provider of diagnostic services in community for dementia [public, private]
Availability of behaviour and psychological management in community for dementia
Accessibility of behaviour and psychological management in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]
Estimated number of people receiving palliative and end-of-life care services in community for dementia
Availability of social and financial protection for dementia
Accessibility of social and financial protection for dementia [Capital/capital and main cities/capital, main cities, rural areas]
Majority provider of social and financial protection for dementia [public, private]
Care facilities [hospice centres]
Availability of atleast one adult hygiene products for people with dementia
Availability of  atleast one assistive technology for people with dementia
Availability of atleast one housing adjustment for people with dementia
Existence of dementia national nongovernmental organization
Majority provider of dementia carer training and education (Public sector)
Majority provider of dementia carer training and education (Private sector)
Majority provider of dementia carer training and education (NGO)
Estimated number of dementia carers receiving training and education
Existence of information on legal rights for dementia carers
Accessibility of information on legal rights for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]
Majority provider of information  on legal rights for dementia carers (Public sector)
Majority provider of information on legal rights for dementia carers (Private sector)
Majority provider of information on legal rights for dementia carers (NGO)
Existence of dementia-friendly initiative to improve accessibility of public spaces
Existence of dementia-friendly initiative to improve accessibility of public transportation
Existence of dementia-friendly initiative for assistance with home modification
Existence of dementia-friendly initiative with assistive technology for loss of capacity
Data sources used to routinely monitor people with dementia (Household surveys)
Data sources used to routinely monitor people with dementia (Administrative data)
Data sources used to routinely monitor people with dementia (Facility survey or records)
Data sources used to routinely monitor people with dementia (Other)
Identification of other research plans in which dementia is integrated (Neuro or neurodegenerative disease)
Identification of other research plans in which dementia is integrated (NCD)
Implementation level [national/subnational] of research plan in which dementia is integrated
Compliance with international health regulations
Number of neurologists (per 100,000)
Number of geriatricians or psychogeriatricians (per 100,000)
Dementia-specific hospital beds (per 10,000 population)
Geriatric-specific hospital beds (per 10,000 population)
Availability and status of dementia reporting in the past two years
Availability of funding for dementia-specific research plan/programme
Total expenditure on dementia research (local currency, self-report)
Total expenditure on dementia basic research (local currency, self-report)
Skilled health professionals density (per 10 000 population)
Number of physicians
Number of midwifery personnel
Number of pharmaceutical technicians/assistants
Number of laboratory scientists
Number of dentists
Number of traditional medicine practitioners
Number of laboratory health workers
Number of community and traditional health workers
Physicians density (per 1000 population)
Dentistry personnel density (per 1000 population)
Pharmaceutical personnel density (per 1000 population)
Laboratory health workers density (per 1000 population)
Other health workers density (per 1000 population)
Reported treatment coverage for substance dependence
Government-supported health internet sites provide information in multiple languages
Proportion of donor/non public development funding
Public-private partnerships for eHealth
National eHealth strategy refers to objectives of UHC
Tertiary institutions provide students of health sciences with training on eHealth
National eHealth strategy
Providing guidance on privacy and security
Regulatory oversight of mobile apps for quality, safety and reliability
Government-sponsored mHealth programmes are being evaluated
Funding
Promoting the development and adoption of mHealth
Strategy includes objectives as to how telehealth contributes to UHC
Lack of infrastructure
eLearning programmes for in-service training of health professionals have been evaluated
Improving access to content and experts
Lack of national or international standards for interoperability of EHR
Competing health system priorities
to protect privacy of personally identifiable data of individuals irrespective of whether it is paper or digital format
which allows for the sharing of personal and health data between research entities
Country has national policy or strategy regulating the use of big data by private companies
Privacy and security laws need to be in place
Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol)
Inclusion of dementia in ministry portfolio
Existence of dementia representative in ministry
Inclusion of equity as a guiding principle of the dementia plan
Inclusion of empowerment as a guiding principle of the dementia plan
Inclusion of multisectoral collaboration as a guiding principles of the dementia plan
Inclusion of universal health coverage as a guiding principle of the dementia plan
Inclusion of dementia-friendly communities as a specific action of the dementia plan
Existence of legislation to promote monitoring of human rights conditions of people with dementia in facilities where they reside
Existence of standards/ guidelines/ protocols for treatment and support of carers and families of people with dementia
Availability of mechanisms to coordinate dementia care across sectors
Identification of different sectors in dementia care coordination  (Health)
Identification of different sectors in dementia care coordination (Social)
Inclusion of basic dementia competencies in training of physicians
Inclusion of basic dementia competencies in training of specialists
Inclusion of basic dementia competencies in training of nurses
Inclusion of basic dementia competencies in training of pharmaceutical personnel
Inclusion of basic dementia competencies in training of social workers
Majority provider of psychosocial and rehabilitation services in community for dementia [public, private]
Estimated number of people receiving psychosocial and rehabilitation services in community for dementia
Availability of activities of daily living suppport services in community for dementia
Accessibility of activities of daily living support services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]
Estimated percentage of hospitals following national dementia standards
Care facilities [long-term care]
Estimated number of people with dementia receiving services at outpatient health centre
Outpatient social centres
Dementia nongovernmental organization staff primarily salaried/volunteer
Provision of governmental funding to dementia nongovernmental organization for activities/services
Dementia nongovernmental organization's involvement in policy development
Existence of dementia carer support services
Implementation level [national/subnational] of dementia carer support services
Majority provider of psycho-social supports for dementia carers (NGO)
Estimated number of dementia carers receiving psycho-social supports
Existence of respite care for dementia carers
Accessibility of respite care for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]
Majority provider of information on financial benefits/social protection for dementia carers (Private sector)
Majority provider of information on financial benefits/social protection for dementia carers (NGO)
Estimated number of dementia carers receiving financial benefits/social protection
Existence of at least one functioning dementia awareness campaign
Existence of dementia training for police and fire services
Existence of dementia training for first responders
Existence of dementia training for legal professionals
Existence of dementia training for community workers
Existence of dementia training for school children
Availability of routine outpatient intervention and treatment records for people with dementia for monitoring purposes
Availability of routine pharmaceutical records for people with dementia for monitoring purposes
Availability of routine antipsychotic prescription records for people with dementia for monitoring purposes
Number of people with dementia involved in research routinely monitored
Availability of investigational pharmaceutical trials for dementia
Number of investigational pharmaceutical trials for dementia
Inclusion of dementia in a branch of government [health, ageing, social services, mental health, noncommunicable disease]
Hospice centre beds (per 10 000 population)
Dementia-specific hospice care beds (per 10,000 population)
Density of adult day centres (per 100,000 population)
Adult day centre places (per 10,000 population)
Men who have sex with men (MSM) with active syphilis (%)
Number of nursing personnel
Number of pharmacists
Nursing and midwifery personnel density (per 1000 population)
Estimated population-based prevalence of depression
Population (in thousands) total
National  health information system (HIS) policy or strategy
Capacity
Infrastructure
Legal
Cost-effectiveness
Providing oversight and enforcement of data ownership
mHealth programmes are sponsored by government
Reducing cost of delivering content
Competing educational priorities
Lack of evidence that eLearning is effective
Insitutional educational policy does not include eLearning as an approach to teaching health sciences
Lack of evidence showing cost-effectiveness or EHR
which governs the sharing of digital data between health professionals in other health services in the same country through the use of an EHR
which governs the sharing of digital data between health professionals  in health services in other countries through the use of an EHR
Policy or strategy makes specific reference tothe use of social media in the health domain
to address patient safety and quality of care based on data quality, data transmission standards, or clinical competency criteria
which allows individuals electronic access to their own health-related data when held in an EHR
which allows individuals to demand the deletion of health-related data from their EHR
Effective standards and best practices for data capture not fully established
Insufficient incentives for data sharing
Capacity building required for new skills
Ill-defined causes in cause-of-death registration (%)
Adult mortality rate (probability of dying between 15 and 60 years per 1000 population)
Existence of evidence-based national guidelines/protocols/standards for the management of major NCDs through a primary care approach
Implementation of physical activity public awareness program
Existence of a set of time-bound national targets based on WHO guidance
Average of 13 International Health Regulations core capacity scores, 1st version of the questionnaire
Dementia integrated into other national plan
Identification of other plans in which dementia is integrated (Other)
Percentage of sub-national regions covered by dementia plan
Inclusion of dementia risk reduction as a specific action of the dementia plan
Inclusion of dementia workforce training as a specific action of the dementia plan
Existence of legislation for supported decision making for people with dementia
Existence of legislation to promote community-based services for people with dementia
Existence of legislation to end coercieve practices for people with dementia
Implementation level of dementia standards/ guidelines/ protocols (National)
Existence of standards/ guidelines/ protocols for advance care directives, power of attorney or guardianship for people with dementia
Existence of standards/ guidelines/ protocols of care in nursing & residential care facilities for people with dementia
Identification of different sectors in dementia care coordination (Employment)
Identification of different sectors in dementia care coordination (Housing)
Presence of formal agreement/joint plan for dementia care coordination
Inclusion of basic dementia competencies in training of personal support workers
Existence of community-based health or social care services for dementia
Estimated number of people receiving behaviour and psychological management services in community for dementia
Accessibility of psychosocial and rehabilitation services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]
Majority provider of activities of daily living support services in community for dementia [public, private]
Availability of palliative and end-of-life care services in community for dementia
Majority provider of palliative and end-of-life care services in community for dementia [public, private]
Estimated number of people with dementia receiving social and financial protection for dementia
Estimated percentage of residential long-term care facilities following national dementia standards
Adult day centres
Outpatient health centres
Estimated number of people with dementia receiving services at outpatient social centre
Availability of generic anti-dementia medication
Dementia nongovernmental organization office branches (Sub-national)
Dementia nongovernmental organization office branches (National only)
Existence of implementation plan for dementia carer support services
Accessibility of dementia carer training and education [Capital/capital and main cities/capital, main cities, rural areas]
Existence of psycho-social supports for dementia carers
Majority provider of psycho-social supports for dementia carers (Public sector)
Majority provider of respite care for dementia carers (Private sector)
Estimated number of dementia carers receiving respite care
Existence of financial benefits/social protection for dementia carers
Majority provider of information  on financial benefits/social protection for dementia carers (Public sector)
Implementation level [national/subnational] of dementia awareness campaign
Implementation level [national/subnational] of dementia risk reduction campaign
Existence of dementia-friendly initiative supporting social opportunities
Existence of dementia training for volunteers
Existence of dementia training for retail and hospitality staff
Data sources used to routinely monitor people with dementia (Clinical records)
Availability of routine hospital admissions records for people with dementia for monitoring purposes
Implementation level [national/subnational] of dementia research plan/programme
Identification of other research plans in which dementia is integrated (Mental health)
Availability of funding for dementia national plan
Existence of legislation to end discrimination against people with dementia
Density of residential long-term care facilities (per 100,000 population)
Dementia-specific residential long-term care beds (per 10,000 population)
Density of outpatient health centres (per 100,000 population)
Electronic availability of data sources used to routinely monitor people with dementia
Total expenditure on dementia clinical/translational research (local currency, self-report)
Environmental and public health workers density (per 1000 population)
Population proportion under 15 (%)
Total fertility rate (per woman)
Total net official development assistance to medical research and basic health sectors per capita (US$), by recipient country
Proportion of public funding
Institutions offer in-service training to health professionals on ICT for health
strategy refers to the use of ICT to support UHC
Public funding for eHealth
Strategy implementation funding available for eHealth
Donor/ non-public development funding for eHealth
Private funding for eHealth
Proportion ofpublic private partnerships funding
Policy
Effectiveness
Demand
Regulating mobile devices and software
Evaluation of any government-sponsored telehealth programmes
Pre-service eLearning programmes have been evaluated
Lack of funding
Enabling access to education where learning facilities are limited
Not possible to gain a health sciences degree entirely through eLearning
Lack of demand for eLearning programmes
Country has specific legislation governing the use of national EHR system
National strategy does not promote the adoption of EHR
Individuals have the legal right to specify which health-related data from their EHR can be shared with health professionals of their choice
Country has national policy or strategy on the use of social media by government organizations
which allows individuals to demand that their own data be corrected  when held in an EHR if it is known to be inaccurate
Research into new analytical methods needs occur to meet the challenges of working with big data
Births by caesarean section (%)
Estimated direct deaths from major conflicts (per 100 000 population)
Existence of operational policy/strategy/action plan for oral health
Existence of dementia national plan
Targets for monitoring implementation of dementia national plan
Existence of dementia sub-national plan(s)
Inclusion of human rights as a guiding principle of the dementia plan
Inclusion of dementia diagnosis, care and support as a specific action of the dementia plan
Inclusion of support for dementia carers and families as a specific action of the dementia plan
Existence of other laws that apply to the rights of people with dementia
Existence of legislation to file appeals protecting the rights of people with dementia
Existence of dementia standards/ guidelines/ protocols
Implementation level of dementia standards/ guidelines/ protocols (Sub-national)
Existence of standards/ guidelines/ protocols for palliative and end-of-life care for people with dementia
Existence of standards/ guidelines/ protocols of care in hospital for people with dementia
Identification of different sectors in dementia care coordination (Education)
Identification of different sectors in dementia care coordination (Justice)
Availability of dementia care coordination standards/ guidelines/ protocols
Availability of dementia diagnostic rate
Availability of diagnostic services in community for dementia
Majority provider of behaviour and psychological management in community for dementia [public, private]
Availability of psychosocial and rehabilitation services in community for dementia
Estimated number of people receiving activities of daily living support services in community for dementia
Accessibility of palliative and end-of-life care services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]
Dementia care facilities [hospitals]
Estimated number of people with dementia living in residential long-term care
National regulator approval of anti-dementia medication
Availability of at least one anti-dementia medication approved for on-label use reimbursement
Dementia nongovernmental organization equipped with office
Dementia nongovernmental organization office branches (Local)
Existence of dedicated resources for dementia carer support services
Existence of dementia carer training and education
Accessibility of psycho-social supports for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]
Majority provider of psycho-social supports for dementia carers (Private sector)
Majority provider of respite care for dementia carers (Public sector)
Majority provider of respite care for dementia carers (NGO)
Estimated number of dementia carers receiving information on legal rights
Accessibility of financial benefits/social protection for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]
Existence of at least one functioning risk reduction campaign
Availability of dementia-friendly initiatives that improve accessibility
Existence of dementia-friendly initiative supporting community places for older people
Inclusion of dementia training and education for non-health workers
Existence of dementia training for financial service staff
Routine monitoring of people with dementia
Data used to routinely monitor people with dementia can be disaggregated
Availability of routine outpatient visit records for people with dementia for monitoring purposes
Existence of a current dementia research plan/programme
Dementia integrated into other national research plan/programme
Identification of other research plans in which dementia is integrated (Ageing)
Total number of published dementia research output
Existence of legislation for advanced care directives for people with dementia
Existence of legislation to end discrimination against carers of people with dementia
Total dementia hospital admissions (per 100,000)
Residential long-term care beds (per 10 000 population)
Density of hospice centres (per 100,000 population)
Dementia-specific adult day centre places (per 10,000 population)
Density of outpatient social centres (per 100,000 population)
Total expenditure on dementia implementation research (local currency, self-report)
Number of dental technicians/assistants
Community and traditional health workers density (per 1000 population)
Population proportion over 60 (%)
Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%)
National universal health coverage strategy
Proportion of private funding
Providing incentives and guidance for innovation research and evaluation of health
Promoting standards and interoperability
Priorities
Country has telehealth policy or strategy
eLearning courses accredited by continuing medical education or professional licensing bodies
Lack of capacity
eLearning used for in-service training of health professionals
Lack of evidence over cost-effectiveness
eLearning is used in pre-service education to teach health sciences students
Lack of suitable courses available
lack of evidence showing effectiveness of EHR
Country has national EHR
Lack of demand by health professionals and patients
Lack of legislation or regulations covering use of EHR
to protect the privacy of individuals' health-related  data held in electronic format as an EHR
to define medical jurisdiction, liability or reimbursement of eHealth services such as telehealth
Country has  national policy or strategy regulating the use of big data in the health sector
Lack of integration between various health services
Concentrations of fine particulate matter (PM2.5)
Ambient and household air pollution attributable death rate (per 100 000 population)
Ambient and household air pollution attributable death rate (per 100 000 population, age-standardized)
Existence of a register of patients who had rheumatic fever and rheumatic heart disease
Has systems for follow-up/recall to deliver long-term penicillin prophylaxis to patients with rheumatic fever and rheumatic heart disease
Household air pollution attributable deaths
Household air pollution attributable death rate (per 100 000 population)
Household air pollution attributable death rate (per 100 000 population, age-standardized)
Household air pollution attributable DALYs
Household air pollution attributable DALYs (per 100 000 population)
Household air pollution attributable DALYs (per 100 000, age-standardized)
Ambient air pollution attributable death rate (per 100 000 population, age-standardized)
Ambient air pollution attributable death rate (per 100 000 population)
Ambient air pollution attributable DALYs  (per 100 000 population)
Ambient air pollution attributable DALYs  (per 100 000 population, age-standardized)
SDG 3.9.2 WASH deaths
Number of diarrhoea deaths from inadequate hygiene
Number of diarrhoea deaths from inadequate water, sanitation and hygiene
Ambient air pollution attributable YLLs
Alcohol, average daily intake in grams among drinkers with 95%CI
Alcohol, total  (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2020 and 2025
Biomedical engineers density (per 10 000 population)
Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI
Alcohol-related crimes (% of all crimes)
Alcohol-related road traffic crashes, per 100,000 population
Alcohol-related road traffic crashes (% of all traffic crashes)
Cautions and arrests for drink-driving, per 100,000 population
Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI
Cautions and arrests for public drunkenness, per 100,000 population
Adopted written national policy on alcohol, year adopted
Adopted written national policy on alcohol, year revised
Central coordinating entity for alcohol policy implementation
Level of adoption of national alcohol policy
Sectors represented in national alcohol policy
National legislation to prevent illegal alcohol
Advertising restrictions on the internet
Advertising restrictions at point-of-sale
Advertising restrictions on social media
Advertising restrictions in print media
Restrictions on product placement in films/movies
Government support for community action
Sobriety checkpoints
Random breath testing (RBT) use
Price measures
Off-premise sales restrictions at specific events
Off-premise sales restrictions on days
Off-premise sales restrictions at petrol stations
Off-premise sales restrictions on outlet density
Restrictions on sales promotion from producers (parties, events)
Restrictions on sales promotion from retailers (sales below cost)
Restrictions on sales promotion from owners of pubs and bars (alcohol for free)
Restrictions on sponsorship of youth events
Monopoly on exports of alcoholic beverages
Licensing required for wholesale/distribution of alcoholic beverages
Licensing required for imports of alcoholic beverages
Government monopoly on retail sales
Monopoly on wholesale /distribution of alcoholic beverages
Duty paid or excise stamp on alcohol container
Restrictions on alcohol use in public places
Tax incentives for production low/no alcohol content beer
Health warning labels on under-age drinking
Alcohol content displayed on containers
Number of standard alcoholic drinks displayed on containers
Licence required for production
Licence required for retail sales
Licenses issued for retail sale, change since 2010
Licenses issued for wholesale/distribution, change since 2010
Alcohol use disorders (15+), 12 month prevalence (%) with 95%
Awareness activities
Server training
National system of data collection based on health service delivery
Heavy episodic drinking (youth 15 -19 years) past 30 days (%)
Alcohol-attributable fractions (15+), road traffic crash deaths (%)
Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%)
Age limits on-premise service
Alcohol, consumption of pure alcohol by type of beverage (%)
National drinking guidelines
Penalties for drink driving, repeated offense
Alcohol, drinkers only per capita (15+)consumption in litres of pure alcohol
Total (recorded+unrecorded) alcohol per capita (15+) consumption
Penalties for drink driving
Consumer information about calories, additives, etc on containers
Alcohol, heavy episodic drinking (15+) past 30 days (%), age-standardized with 95%CI
15-19 years old heavy episodic drinkers (population), % with 95%CI
15-19 years old, current drinkers (%)
National systems for monitoring alcohol consumption and harms
Legislative status
Main sector for treatment for alcohol use disorders
Ambient air pollution attributable deaths in children under 5 years
Household air pollution attributable deaths in children under 5 years
Household air pollution attributable DALYs in children under 5 years
Ambient air pollution attributable DALYs  in children under 5 years
Number of diarrhoea DALYs from inadequate hygiene
Number of diarrhoea DALYs from inadequate water, sanitation and hygiene
Alcohol, abstainers lifetime (%)
Number of biomedical technicians
Alcohol, former drinkers (%)
Action Plan for implementation of alcohol policy
Alcoholic beverage legally defined
Advertising restrictions on cable television
Advertising restrictions on local radio
Restrictions on product placement on cable television
Advertising restrictions on billboards
Level of enforcement of BAC limits
Off-premise sales restrictions on hours
Off-premise sales restrictions on places
On-premise sales restrictions on hours
On-premise sales restrictions on outlet density
On-premise sales restrictions on places
On-premise sales restrictions to intoxicated persons
Restrictions on sponsorship of sporting events
Licensing required for exports of alcoholic beverages
Government monopoly on production
Level of taxation adjusted for inflation
Tax incentives for production of other alcoholic beverages
Health warning labels on alcohol advertising
Licenses issued for production, change since 2010
National guidelines for alcohol problem prevention and counselling at workplaces
Standard drink defined
National surveys on adult alcohol consumption
Report with data from health services on alcohol use and AUDs
15-19 years old heavy episodic drinkers (drinkers only), %
Alcohol-attributable fractions (15+), liver cirrhosis deaths (%)
Road traffic injuries, age-standardized death rates (15+), per 100,000 population
Alcohol-attributable fractions (15+), cancer deaths
Cancer, age-standardized death rates (15+), per 100,000 population
Liver cirrhosis, age-standardized death rates (15+), per 100,000 population
Alcohol-attributable fractions, all-cause deaths (%)
Prevalence of insufficient physical activity among adults aged 18+ years (crude estimate) (%)
Age limits off-premise sales
National legislation to prevent illegal alcohol sales
Alcohol, consumers past 12 months (%)
Advertising restrictions on national television
Health warning labels on alcohol containers
National surveys on youth alcohol consumption
15-years old any alcoholic beverage consumed in past 12 months, (%)
On-premise sales restrictions at specific events
Attributable fraction of diarrhoea to inadequate hygiene
Attributable fraction of diarrhoea to inadequate water, sanitation and hygiene
Number of biomedical engineers
Framework of national alcohol policy
Adopted written national policy on alcohol
Advertising restrictions on national radio
Advertising restrictions at cinemas
Detection of marketing infringements
Penalties for marketing infringements
On-premise sales restrictions on days
Monopoly on imports of alcoholic beverages
Excise tax on alcoholic beverages
Taxation of ethanol production
Value-added tax (VAT) on alcohol (%)
Legal requirement for size of health warning labels
National guidelines for the prevention and reduction of alcohol-related harm in schools
National organization for monitoring alcohol
Graduated licensing
Legal blood alcohol concentration (BAC) limits
Heavy episodic drinking (youth 15 -19 years), drinkers only, past 30 days (%)
13-15-years old first drink before age 14, (%)
Average price 500 mls Spirits in US$
Distribution of causes of death among children aged < 5 years (%)
Deaths per 1 000 live births
Existence of tax on sugar-sweetened beverages
Biomedical technicians density (per 10 000 population)
Restrictions on product placement on national television
Health warning labels on pregnancy
Health warning labels on drink-driving
Ethanol tax deducted from excise tax
Legislation on alcohol testing at workplaces
National system of epidemiological data collection for alcohol use
Report with epidemiological data on lcohol use and AUDs
Alcohol-attributable Years of Life Lost (YLL) score
Alcohol use is banned
Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average with 95%CI
Alcohol use disorders (15+), 12 month prevalence (%), age standardized, with 95%CI
13-15-years old any alcoholic beverage consumed in past 30 days, (%)
Average price 500 mls Beer in US$
Average price 750 mls Wine in US$
Number of new leprosy cases
Leprosy - Number of cases registered for treatment
Leprosy - Number of new G2D cases
Leprosy - Number of new child (less than 15 years of age) cases detected with G2D
Leprosy - Number of female new cases
Presence of porcine cysticercosis
Leprosy - New leprosy cases with G2D rate per 1 000 000 population
Leprosy - New cases detection rate per 100 000 population
Leprosy - Registered cases per 10 000 population
Participation rate in organized learning (one year before the official primary entry age) (%)
Proportion of children in grades 2/3 achieving at least a minimum proficiency level in mathematics (%)
Proportion of children in grades 2/3 achieving at least a minimum proficiency level in reading (%)
Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in mathematics (%)
Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in reading (%)
Proportion of children at the end of primary achieving at least a minimum proficiency level in mathematics (%)
Low birth weight, prevalence (%)
Low birth weight (in thousands)
Population using safely managed drinking-water services (%)
Population using at least basic drinking-water services (%)
Population using safely managed sanitation services (%)
Population using at least basic sanitation services (%)
Population practising open defecation (%)
Proportion of population below the international poverty line of US$1.90 per day (%)
Data availability for UHC index of service coverage
Poliomyelitis - number of reported cases
Number of maternal deaths
Maternal mortality ratio (per 100 000 live births)
Leprosy - Number of new child (less than 15 years of age) cases
Prevalence of insufficient physical activity among school going adolescents aged 11-17 (crude estimate)
Increase in poverty gap due to household health expenditures at the $1.90 a day poverty line, in cents of international dollars
Population pushed below the $3.20 a day poverty line by household health expenditures (%)
Increase in poverty gap due to household health expenditures, expressed as a proportion of the $3.20 a day poverty line (%)
Increase in poverty gap due to household health expenditures at the $3.20 a day poverty line, in cents of international dollars
Increase in poverty gap due to household health expenditures, expressed as a proportion of the $1.90 a day poverty line (%)
Population with household expenditures on health greater than 25% of total household expenditure or income (SDG indicator 3.8.2) (%)
Population pushed below the $1.90 a day poverty line by household health expenditures (%)
Population pushed below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (%)
Increase in poverty gap due to household health expenditures, expressed as a proportion of a relative poverty line (60% of median daily per capita consumption or income) (%)
Reporting countries
Proportion of isolates with resistance to azithromycin reported to WHO-GASP
Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP
Number of isolates tested for azithromycin
Number of isolates tested for cefixime
Number of isolates tested for ciprofloxacin
Number of isolates tested for ceftriaxone
Number of isolates tested for extended-spectrum cephalosporins
Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP
Existence of national policies on saturated fatty acids
Existence of national policies on trans-fatty acid elimination
Prevalence of current tobacco use among persons aged 15 years and older (age-standardized rate)
Availability of estimates on large health expenditures as a share of total expenditure or income
Average death rate due to natural disasters (per 100 000 population)
Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2)
Proportion of children at the end of primary achieving at least a minimum proficiency level in reading (%)
Publication year of the policy or plan (latest revision)
Nurses working in mental health sector (per 100 000 population)
Mental health outpatient facilities (per 100 000 population)
UHC SCI components: Reproductive, maternal, newborn and child health
UHC SCI components: Noncommunicable diseases
Data availability for UHC index of service coverage (ranking)
Population with household expenditures on health greater than 10% of total household expenditure or income (SDG indicator 3.8.2) (%)
Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP
Estimated number of tests performed where results were received by a person (testing volume), estimated number per 1000 population
Number of registered vehicles
General availability of bone marrow transplantation in the public health system
ICD-11 implementation progress level
Distribution of road traffic deaths by type of road user (%)
Persistence to last grade of primary (% of cohort)
Alcohol, total per capita (15+) consumption (in litres of pure alcohol) with 95%CI
Status of endemicity of Taenia solium
Number of pigs in the country
Completeness of cause-of-death data (%)
Mental hospitals (per 100 000 population)
Beds in mental hospitals (per 100 000 population)
Mental health units in general hospitals (per 100 000 population)
Beds for mental health in general hospitals (per 100 000 population)
Community residential facilities (per 100 000 population)
Average of 13 International Health Regulations core capacity scores, SPAR version
UHC SCI components:  Infectious diseases
UHC SCI components: Service capacity and access
Reported number of tests performed where results were received by a person (testing volume)
General availability of Angiotensin II receptor blockers (ARBs) in the public health sector
Availability of estimates on impoverishment due to out-of-pocket health expenditures
Practice of backyard pig production
Government expenditures on mental hospitals as a percentage of total government expenditures on mental health (%)
Psychiatrists working in mental health sector (per 100 000 population)
Beds in community residential facilities (per 100 000 population)
Mental health day treatment facilities (per 100 000 population)
Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP
Reported number of tests performed where results were received by a person (testing volume), reporting period
Proportion of health facilities with a core set of relevant essential medicines available and affordable on a sustainable basis
Formative research was conducted prior to the campaign
Outcome evaluation was employed to assess effectiveness of the campaign
Campaign was part of a comprehensive tobacco control programme
Campaign was pre-tested
Process evaluation was employed to assess implementation of the campaign
Campaign utilized media planning
At least one national mass media campaign ran during the survey period
Earned media/public relations were used to promote the campaign
Campaign ran on both national television and radio
Overall compliance with bans on promotion and sponsorship (score)
Compliance with ban on advertising on national television and radio (score)
Compliance with ban on appearance of tobacco products in TV and/or films (score)
Compliance with ban on sponsorship (contributions and/or publicity of contributions) (score)
Subnational bans on advertising, promotion and sponsorship - at least one jurisdiction has a comprehensive ban in place
Enforce bans on tobacco advertising
Ban on advertising on national television and radio
Overall compliance with bans on direct advertising (score)
Compliance with ban on promotional discounts (score)
Compliance with ban on appearance of tobacco brands in TV and/or films (score)
Compliance with ban on advertising in local magazines and newspapers (score)
Compliance with ban on free distribution in mail or through other means (score)
Ban on promotional discounts
Ban on identifying non-tobacco products with tobacco brand names
Ban on appearance of tobacco brands in TV and/or films (product placement)
Ban on appearance of tobacco products in TV and/or films
Ban on sponsorship (contributions and/or publicity of contributions)
Ban on any form of contribution (financial or other support) to any event, activity or individual
Ban on Corporate Social Responsibility activities (CSR)
Ban on tobacco companies/the tobacco industry publicizing their CSR activities
Ban on tobacco companies funding or making contributions (including in-kind contributions) to smoking prevention media campaigns, including those directed at youth
Ban on advertising on international television and radio
Law requires fines for violations of promotion and sponsorship bans
Subnational bans on tobacco advertising, promotion and sponsorship authority exists
Ban on internet sales of tobacco products
Ban on advertising in local magazines and newspapers
Ban on billboard and outdoor advertising
Ban on advertising at point of sale
Ban on advertising on the internet
Ban on free distribution in mail or through other means
Budget year
Number of full-time equivalent staff in national agency
Annual budget for tobacco control in currency reported
Bupropion - cost covered
Cytisine - cost covered
Cytisine - place available
Offer help to quit tobacco use
Smoking cessation support is cost-covered in health clinics or other primary care facilities
Smoking cessation support is cost-covered in hospitals
Smoking cessation support is cost-covered in other settings
Nicotine replacement therapy - on the Essential Medicines List
Varenicline - cost covered
Overall compliance with regulations on smoke-free environments (score)
Compliance with smoke-free universities law (score)
Compliance with smoke-free restaurants law (score)
Subnational smoking bans - at least one jurisdiction has a comprehensive ban in place
Number of places smoke-free (national legislation)
Smoke-free health-care facilities (national legislation)
Subnational smoke-free legislation authority exists
Fines on the establishment for violations of smoke-free laws
Fines on the patrons of establishments for violations of smoke-free laws
Citizen complaints and investigations of violations of smoke-free laws
Smoke-free education facilities except universities (national legislation)
Smoke-free indoor offices (national legislation)
Smoke-free public transport (national legislation)
Smoke-free other indoor public places (national legislation)
Tax stamps, fiscal marks, banderole or other types of marking are applied on other tobacco products
Affordability - percentage of GDP per capita required to purchase 2000 cigarettes of the most sold brand
Price dispersion: Share of cheapest brand price in premium brand price (%) (the higher the % the smaller the gap)
Retail price used as base of ad valorem component in ad valorem or mixed excise regime (or retail price exclusive of VAT)
Uniform excise tax applied Yes (Uniform), No (Tiered/varying rates)
Raise taxes on tobacco
Most sold brand of cigarettes - taxes as a % of price - import duties
Most sold brand of cigarettes - taxes as a % of price - other taxes
Most sold brand of cigarettes - taxes as a % of price - specific excise
Most sold brand of cigarettes - taxes as a % of price - total tax
Warn about the dangers of tobacco
Number of health warnings approved by the law for cigarette packaging
Health warnings on cigarette packaging law requires or establishes fines for violations
Ban on deceitful terms on cigarette packaging
Cigarette packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
Percentage of principal display area mandated to be covered by health warnings - front and back of cigarette packaging
Cigarette packaging and labelling must not use descriptors depicting flavours
Cigarette packaging and labelling must display qualitative information on emission yields
Emission yields must be displayed on one or more principle display areas of cigarette packaging
Display of expiry dates is prevented on cigarette packaging
The quit line number must appear on cigarette packaging or labelling
Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)
Percentage of principal display area mandated to be covered by health warnings - back of cigarette packaging
Health warnings on cigarette packaging must be placed at the top of the principal display areas of the package
Font style, font size and colour of health warnings are mandated for cigarette packaging
Health warnings on cigarette packaging must be rotated
Health warnings on cigarette packaging must be written in the principal language(s) of the country
Health warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stamps
Anti-tobacco mass media campaigns
Representativeness of most recent survey of adults
Representativeness of most recent adolescent survey
Name of latest youth prevalence survey (nonsmoked)
Age range of latest youth prevalence survey (nonsmoked)
Prevalence of current tobacco use among adolescents (%)
Prevalence of daily tobacco use among adolescents (%)
Prevalence of current tobacco smoking among adolescents (%)
Prevalence of daily tobacco smoking among adolescents (%)
Prevalence of current cigarette smoking among adolescents (%)
Prevalence of daily cigarette smoking among adolescents (%)
Prevalence of current smokeless tobacco use among adolescents (%)
Prevalence of daily smokeless tobacco use among adolescents (%)
Prevalence of current e-cigarette use among adolescents (%)
Prevalence of daily e-cigarette use among adolescents (%)
Prevalence of current tobacco use among adults (%)
Prevalence of daily tobacco use among adults (%)
Prevalence of current tobacco smoking among adults (%)
Prevalence of daily tobacco smoking among adults (%)
Prevalence of current cigarette smoking among adults (%)
Prevalence of daily cigarette smoking among adults (%)
Prevalence of current smokeless tobacco use among adults (%)
Prevalence of daily smokeless tobacco use among adults (%)
Prevalence of current e-cigarette use among adults (%)
Prevalence of daily e-cigarette use among adults (%)
Mean fasting blood glucose (mmol/l) (age-standardized estimate)
Alcohol, abstainers past 12 months (%)
Institutional Births (birth taken place in a facility) (%)
Blood Alcohol Concentration (BAC) limit for drivers
Existence of a national seat-belt law
Applicability of seat-belt law to all occupants
Seat-belt wearing rate (%)
Existence of a national drink-driving law
Attribution of road traffic deaths to alcohol (%)
Existence of a national road safety strategy
Vehicle standards
Estimate of daily tobacco use prevalence (%)
Estimate of daily tobacco use prevalence (%) (age-standardized rate)
Estimate of daily cigarette smoking prevalence (%) (age-standardized rate)
Estimate of daily tobacco smoking prevalence (%)
Estimate of daily tobacco smoking prevalence (%) (age-standardized rate)
Estimate of current cigarette smoking prevalence (%)
Estimate of daily cigarette smoking prevalence (%)
Estimate of current cigarette smoking prevalence (%) (age-standardized rate)
Estimate of current tobacco smoking prevalence (%) (age-standardized rate)
Estimate of current tobacco use prevalence (%)
Estimate of current tobacco use prevalence (%) (age-standardized rate)
Estimate of current tobacco smoking prevalence (%)
Health warnings on other smoked tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale
Health warnings on other smoked tobacco packaging do not remove or diminish the liability of the tobacco industry
Other smoked tobacco packaging and labelling must not use descriptors depicting flavours
Other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
Display of expiry dates is prevented on other smoked tobacco packaging
Plain packaging of other smoked tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)
Compliance with ban on use of brand name of non-tobacco product for tobacco product (score)
Compliance with ban on indentifying non-tobacco products with tobacco brand names (score)
Compliance with ban on billboard and outdoor advertising (score)
Compliance with ban on advertising at point of sale (score)
Ban on use of brand name of non-tobacco product for tobacco product
Banning the publicity of financial or other sponsorship or support by the tobacco industry of events, activities, individuals
Ban on entities other than tobacco companies/the tobacco industry publicizing the CSR activities of the tobacco companies/industry
Law requires fines for violations of advertising bans
Ban on tobacco vending machines
Ban on advertising in international magazines and newspapers
Ban on product display at point of sale
Monitor
National tobacco control budget - currency reported
Government objectives on tobacco control exist
Cytisine - legally sold
Smoking cessation support is cost-covered in the community
Smoking cessation support is cost-covered in offices of health professionals
Nicotine replacement therapy - cost covered
Compliance with smoke-free indoor offices law (score)
Protect from tobacco smoke
Fines for violations of smoke-free laws
Dedicated funds for enforcement of smoke-free laws
Smoke-free universities (national legislation)
Smoke-free government facilities (national legislation)
Smoke-free restaurants (national legislation)
Smoke-free pubs, bars and cafés (national legislation)
Most sold brand of cigarettes - taxes as a % of price - ad valorem excise
Ban on sale of duty-free or excise-free cigarettes
Specific tax component automatically adjusted for inflation (or other)
Greater reliance on specific tax  in mixed excise regime
A minimum price policy is implemented
Most sold brand of cigarettes - taxes as a % of price - value added tax
Tobacco tax revenues - total revenues
Tobacco tax revenues - import duties and all other taxes
Law mandates that health warnings appear on cigarette packages
Health warnings on cigarette packaging must include a photograph or graphic
Health warnings appear on each cigarette package and any outside packaging and labelling used in the retail sale
Health warnings on cigarette packaging law applys to products whether manufactured domestically imported AND for duty-free sale
Health warnings on cigarette packaging do not remove or diminish the liability of the tobacco industry
Health warnings on cigarette packaging describe the harmful effects of tobacco use on health
Specific health warnings are mandated for cigarette packaging
Age range of most recent survey of adults
Title of most recent survey of adults
Name of latest adult prevalence survey (nonsmoked)
Representation of latest adult prevalence survey (nonsmoked)
Year of most recent adolescent survey
Year of latest youth prevalence survey (nonsmoked)
Representation of latest youth prevalence survey (nonsmoked)
Availability of funding for national road safety strategy
Law mandates that health warnings appear on other smoked tobacco packages
Health warnings on other smoked tobacco packaging law requires or establishes fines for violations
Ban on deceitful terms on other smoked tobacco packaging
Other smoked tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
Other smoked tobacco packaging and labelling must display qualitative information on emission yields
Emission yields must be displayed on one or more principle display areas of other smoked tobacco packaging
The quit line number must appear on other smoked tobacco packaging or labelling
Health warnings on other smoked tobacco packaging must be placed at the top of the principal display areas of the package
Health warnings on other smoked tobacco packaging must not be obscured in any way including by required markings such as tax stamps
Law mandates that health warnings appear on smokeless tobacco packages
Health warnings on smokeless tobacco packaging must include a photograph or graphic
Health warnings on smokeless tobacco packaging describe the harmful effects of tobacco use on health
Health warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail sale
Compliance with smoke-free health-care facilities law (score)
Compliance with smoke-free government facilities law (score)
Compliance with smoke-free pubs and bars law (score)
Tax stamps, fiscal marks, banderole or other types of marking are applied on cigarettes
Minimum specific tax applied in ad valorem or mixed excise regime
Type of excise tax applied.
Tobacco tax revenues - total excise (specific and ad valorem)
Tobacco tax revenues - tobacco product types included
Year of most recent survey of adults
Applicability of national motorcycle helmet law to all occupants
Definition of drink-driving by BAC
Ban on sale of smokeless tobacco products
Specific health warnings are mandated for smokeless tobacco packaging
Number of health warnings approved by the law for smokeless tobacco packaging
National agency for tobacco control exists
Compliance with smoke-free education facilities except universities law (score)
Compliance with smoke-free public transport law (score)
Affordability - category of change since 2008 (more affordable/less affordable/no change)
Reported use of earmarked tobacco taxes
Tobacco tax revenues - currency reported
Tobacco tax revenues - valued added tax (VAT) and other sales taxes
Tobacco tax revenues - year reported
Year of latest adult prevalence survey (nonsmoked)
Age range of latest adult prevalence survey (nonsmoked)
Age range of most recent adolescent survey
Title of most recent adolescent survey
Existence of a national child-restraint law
Existence of national speed limits
Maximum speed limits
Law requires helmet to be fastened
Existence of a road safety lead agency
Existence of a universal access telephone number for pre-hospital care
Percentage of principal display area mandated to be covered by health warnings - front and back of smokeless tobacco packaging
Percentage of principal display area mandated to be covered by health warnings - front of smokeless tobacco packaging
Percentage of principal display area mandated to be covered by health warnings - back of smokeless tobacco packaging
Font style, font size and colour of health warnings are mandated for smokeless tobacco packaging
Health warnings on smokeless tobacco packaging must be written in the principal language(s) of the country
Health warnings on smokeless tobacco packaging must be rotated
Health warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industry
Smokeless tobacco packaging and labelling must not use descriptors depicting flavours
Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)
Health warnings on smokeless tobacco packaging law requires or establishes fines for violations
Smokeless tobacco packaging and labelling must display qualitative information on emission yields
The quit line number must appear on smokeless tobacco packaging or labelling
Health warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale
Smokeless tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
Health warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stamps
Emission yields must be displayed on one or more principle display areas of smokeless tobacco packaging
Display of expiry dates is prevented on smokeless tobacco packaging
Smokeless tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
Ban on deceitful terms on smokeless tobacco packaging
Health warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the package
Percentage of principal display area mandated to be covered by health warnings - front of cigarette packaging
Hospital beds (per 10 000 population)
Number of new HIV infections
Estimated number of people (all ages) living with HIV
Reported number of people receiving antiretroviral therapy
Number of deaths due to HIV/AIDS
Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine)  for preventing mother-to-child transmission
Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission
Estimated antiretroviral therapy coverage among children
Reported number of children receiving antiretroviral therapy
Prevalence of HIV among adults aged 15 to 49 (%)
Estimated antiretroviral therapy coverage among people living with HIV (%)
Estimated number of children needing antiretroviral therapy based on WHO methods
Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods
Most sold brand of cigarettes - currency reported
Most sold brand of cigarettes - price in currency reported
Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)
Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%)
Hepatitis B (HepB3) immunization coverage among 1-year-olds (%)
Hib (Hib3) immunization coverage among 1-year-olds (%)
BCG immunization coverage among 1-year-olds (%)
Polio (Pol3) immunization coverage among 1-year-olds (%)
Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%)
Alcohol, heavy episodic drinking (15+), drinkers only, past 30 days (%)
New HIV infections (per 1000 uninfected population)
Tuberculosis effective treatment coverage (%)
New child (less than 15 years of age) leprosy cases rate per 1 000 000 population of children
Number of under-five deaths
Number of infant deaths
Number of neonatal deaths
Infant mortality rate (probability of dying between birth and age 1 per 1000 live births)
Under-five mortality rate (probability of dying by age 5 per 1000 live births)
Pneumococcal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%)
Neonatal mortality rate (per 1000 live births)
Number of reported cases of poliomyelitis by wild poliovirus (WPV)
Deaths due to tuberculosis among HIV-negative people (per 100 000 population)
Incidence of tuberculosis (per 100 000 population per year)
Tuberculosis treatment coverage
Status of yaws endemicity
Cheapest brand of cigarettes - price in currency reported
Premium brand of cigarettes - price in currency reported
New cases tested for RR-/MDR-TB (%)
Previously treated cases tested for RR-/MDR-TB (%)
Treatment success rate for patients treated for MDR-TB (%)
Cases started on MDR-TB treatment
Treatment success rate: new TB cases
Treatment success rate: previously treated TB cases
Treatment success rate: HIV-positive TB cases
Number of incident tuberculosis cases
Incidence of tuberculosis (per 100 000 population) (HIV-positive cases)
Number of incident tuberculosis cases,  (HIV-positive cases)
Number of deaths due to tuberculosis, excluding HIV
TB patients with known HIV status (%)
Tested TB patients HIV-positive (%)
New or unknown treatment history cases: Pulmonary, clinically diagnosed
New cases: extrapulmonary
New or unknown treatment history cases: Pulmonary, bacteriologically confirmed
New cases: Pulmonary, smear-negative/unknown/not done and other new cases
New cases: Pulmonary, smear-positive
Previously treated  cases, excluding relapse
Relapse cases (pre-2013 definition)
Relapse cases: Pulmonary, clinically diagnosed
Relapse cases: extrapulmonary
Confirmed cases of RR-/MDR-TB
Stillbirth rate (per 1000 total births)
Diphtheria - number of reported cases
Pertussis - number of reported cases
Total tetanus - number of reported cases
Yellow fever - number of reported cases
Mumps - number of reported cases
Congenital Rubella Syndrome - number of reported cases
Neonatal tetanus - number of reported cases
Total rubella - number of reported cases
Measles - number of reported cases
Legislation and Financing
IHR Coordination and National IHR Focal Point Functions
Human Resources
National Health Emergency Framework
Health Service Provision
Points of Entry
Radiation Emergencies
Life expectancy at age 60 (years)
Healthy life expectancy (HALE) at age 60 (years)
Life expectancy at birth (years)
Healthy life expectancy (HALE) at birth (years)
nMx - age-specific death rate between ages x and x+n
ndx - number of people dying between ages x and x+n
Treatment history unknown
Relapse cases: Pulmonary, bacteriologically confirmed
UHC index of service coverage (SCI)
Japanese encephalitis - number of reported cases
Zoonotic Events and the Human-animal Interface
Food Safety
Risk Communication
Chemical Events
nqx - probability of dying between ages x and x+n
Estimated number of MDR/RR-TB incident cases
HIV-positive TB patients on ART (antiretroviral therapy) (%)
Number of incident tuberculosis cases in children aged 0 - 14
lx - number of people left alive at age x
nLx - person-years lived between ages x and x+n
Tx - person-years lived above age x
ex - expectation of life at age x
Population with primary reliance on clean fuels and technologies for cooking (in millions)
Proportion of population with primary reliance on clean fuels and technologies for cooking (%)
Population with primary reliance on polluting fuels and technologies for cooking (in millions)
Proportion of population with primary reliance on polluting fuels and technologies for cooking (%)
Current health expenditure (CHE) per capita in PPP int$
Current health expenditure (CHE) per capita in US$
Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%)
External health expenditure (EXT) per capita in PPP int$
External health expenditure (EXT) per capita in US$
External health expenditure (EXT) as percentage of current health expenditure (CHE) (%)
Domestic general government health expenditure (GGHE-D) per capita in PPP int$
Domestic general government health expenditure (GGHE-D) per capita in US$
Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE) (%)
Domestic general government health expenditure (GGHE-D) as percentage of gross domestic product (GDP) (%)
Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%)
Out-of-pocket expenditure (OOP) per capita in PPP int$
Out-of-pocket expenditure (OOP) per capita in US$
Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%)
Domestic private health expenditure (PVT-D) per capita in PPP int$
Domestic private health expenditure (PVT-D) per capita in US$
Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%)
Age-standardized suicide rates (per 100 000 population)
Total NCD Deaths (in thousands)
Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease
Estimated number of road traffic deaths
Estimated road traffic death rate (per 100 000 population)
Number of deaths attributed to non-communicable diseases, by type of disease and sex
Mortality rate attributed to unintentional poisoning (per 100 000 population)
Crude suicide rates (per 100 000 population)
Estimates of number of homicides
Estimates of rates of homicides per 100 000 population
Age-standardized NCD mortality rate  (per 100 000 population)
Physiotherapy Technicians and Assistants (number)
Nursing and midwifery personnel  (number)
Medical and Pathology Laboratory scientists (number)
Dentists (number)
Midwifery personnel (number)
Medical doctors not further defined (number)
Nursing personnel (number)
Specialist medical practitioners (number)
Medical doctors (number)
Nursing and midwifery personnel (per 10 000 population)
Medical doctors (per 10 000 population)
Nursing personnel (%)
Medical doctors (%)
Pharmacists  (per 10 000 population)
Births in baby-friendly facilities (%)
Population below the international poverty line (%)
Nutrition Governance score
International Code on Marketing of Breast-milk Substitutes: Legal status of the Code
Maternity protection: Compliance with international labour standards
GDP per capita annual growth rate (%)
Reported number of people requiring interventions against NTDs
Women of reproductive age (15−49 years) who are married or in-union who have their need for family planning satisfied with modern methods (%), UNPD
Premature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths (%)
Physiotherapists (number)
Pharmacists (number)
Environmental and Occupational Health and Hygiene Professionals  (number)
Generalist medical practitioners (number)
Dentists (per 10 000 population)
NLIS: Population using improved drinking-water sources (%)
NLIS: Population using improved sanitation facility (%)
Births attended by skilled health personnel (%)
Adolescent birth rate (per 1000 women aged 15-19 years)
Legally-binding controls on lead paint
Traditional and Complementary Medicine Professionals  (number)
Dental Assistants and Therapists (number)
Status of endemicity of cutaneous leishmaniasis
Status of endemicity of visceral leishmaniasis
Pharmaceutical Technicians and Assistants (number)
Girls aged 15 years old that received the recommended doses of HPV vaccine (%)
Prevalence of anaemia in children aged 6–59 months (%)
Number of children aged 6–59 months with anaemia (thousands)
Number of women of reproductive age (aged 15-49 years) with anaemia (thousands)
Number of non-pregnant women (aged 15-49 years) with anaemia (thousands)
Number of pregnant women (aged 15-49 years) with anaemia (thousands)
Prevalence of underweight children under 5 years of age   (% weight-for-age <-2 SD) (%)
Prevalence of wasted children under 5 years of age   (% weight-for-height <-2 SD)
Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (SDG Indicator 3.5.2)
Overweight prevalence among children under 5 years of age (%)
Stunting prevalence among children under 5 years of age (%)
Best-practice policy implemented for industrially produced trans-fatty acids (TFA) (Y/N)
Prevalence of anaemia in pregnant women (aged 15-49) (%)
Prevalence of anaemia in non-pregnant women (aged 15-49) (%)
Prevalence of anaemia in women of reproductive age (aged 15-49) (%)
Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years)
Status of elimination of trachoma as a public health problem
Proportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in their lifetime
Proportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months
